exovir inc said european patent office notified its application covering combinations nonionic surfactants and all forms interferon has been approved and patent will issued about six months exovir completing trials gel combining alpha interferon and nonoxynol antiviral surfactant treatment for genital and oral herpes and genital warts gel was given patent 1985 said clinical tests will shortly test whether gel effective preventing transmission aids virus when used with condom reuter 